Evidence map›Paper›PMID 27194811›Full record

ArticleJournal of lipid research2016

A continuous spectrophotometric assay that distinguishes between phospholipase A1 and A2 activities.

Meddy El Alaoui, Laurent Soulère, Alexandre Noiriel, Florence Popowycz, Abdallah Khatib, Yves Queneau, Abdelkarim Abousalham

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Journal of lipid research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Meddy El AlaouiUniv Lyon, Université Lyon 1, UMR 5246, CNRS, INSA Lyon, CPE Lyon, Institut de Chimie et de Biochimie Moléculaires et Supramoléculaires (ICBMS), Métabolismes, Enzymes et Mécanismes Moléculaires (MEM), F-69622 Villeurbanne, France Univ Lyon, INSA Lyon, UMR 5246, CNRS, Université Lyon 1, CPE Lyon, Institut de Chimie et de Biochimie Moléculaires et Supramoléculaires (ICBMS), Chimie Organique et Bioorganique (COB), F-69621 Villeurbanne, France.
Laurent SoulèreUniv Lyon, INSA Lyon, UMR 5246, CNRS, Université Lyon 1, CPE Lyon, Institut de Chimie et de Biochimie Moléculaires et Supramoléculaires (ICBMS), Chimie Organique et Bioorganique (COB), F-69621 Villeurbanne, France.
Alexandre NoirielUniv Lyon, Université Lyon 1, UMR 5246, CNRS, INSA Lyon, CPE Lyon, Institut de Chimie et de Biochimie Moléculaires et Supramoléculaires (ICBMS), Métabolismes, Enzymes et Mécanismes Moléculaires (MEM), F-69622 Villeurbanne, France.
Florence PopowyczUniv Lyon, INSA Lyon, UMR 5246, CNRS, Université Lyon 1, CPE Lyon, Institut de Chimie et de Biochimie Moléculaires et Supramoléculaires (ICBMS), Chimie Organique et Bioorganique (COB), F-69621 Villeurbanne, France.
Abdallah KhatibUniv Lyon, Université Lyon 1, UMR 5246, CNRS, INSA Lyon, CPE Lyon, Institut de Chimie et de Biochimie Moléculaires et Supramoléculaires (ICBMS), Métabolismes, Enzymes et Mécanismes Moléculaires (MEM), F-69622 Villeurbanne, France.
Yves QueneauUniv Lyon, INSA Lyon, UMR 5246, CNRS, Université Lyon 1, CPE Lyon, Institut de Chimie et de Biochimie Moléculaires et Supramoléculaires (ICBMS), Chimie Organique et Bioorganique (COB), F-69621 Villeurbanne, France.
Abdelkarim AbousalhamUniv Lyon, Université Lyon 1, UMR 5246, CNRS, INSA Lyon, CPE Lyon, Institut de Chimie et de Biochimie Moléculaires et Supramoléculaires (ICBMS), Métabolismes, Enzymes et Mécanismes Moléculaires (MEM), F-69622 Villeurbanne, France abousalham@univ-lyon1.fr.
Institut de Chimie et Biochimie Moléculaires et Supramoléculaires · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new spectrophotometric assay was developed to measure, continuously and specifically, phospholipase A1 (PLA1) or phospholipase A2 (PLA2) activities using synthetic glycerophosphatidylcholines (PCs) containing α-eleostearic acid, either at the sn-1 position [1-α-eleostearoyl-2-octadecyl-rac-glycero-3-phosphocholine (EOPC)] or at the sn-2 position [1-octadecyl-2-α-eleostearoyl-rac-glycero-3-phosphocholine (OEPC)]. The substrates were coated onto the wells of microtiter plates. A nonhydrolyzable ether bond, with a non-UV-absorbing alkyl chain, was introduced at the other sn position to prevent acyl chain migration during lipolysis. Upon enzyme action, α-eleostearic acid is liberated and then solubilized into the micellar phase. The PLA1 or PLA2 activity was measured by the increase in absorbance at 272 nm due to the transition of α-eleostearic acid from the adsorbed to the soluble state. EOPC and OEPC differentiate, with excellent accuracy, between PLA1 and PLA2 activity. Lecitase(®), guinea pig pancreatic lipase-related protein 2 (known to be a PLA1 enzyme), bee venom PLA2, and porcine pancreatic PLA2 were all used to validate the assay. Compared with current assays used for continuously measuring PLA1 or PLA2 activities and/or their inhibitors, the development of this sensitive enzymatic method, using coated PC substrate analogs to natural lipids and based on the UV spectroscopic properties of α-eleostearic acid, is a significant improvement.

Indexed as

AnimalsBeesBee VenomsEnzyme AssaysInsect ProteinsLinolenic AcidsPhosphatidylcholinesPhospholipases A1Phospholipases A2Sus scrofaBee Venomseleostearic acidInsect ProteinsLinolenic AcidsPhosphatidylcholinesPhospholipases A1Phospholipases A21-octadecyl-2-α-eleostearoyl-rac-glycero-3-phosphocholine1-α-eleostearoyl-2-octadecyl-rac-glycero-3-phosphocholinetung oilα-eleostearic acidβ-cyclodextrin

Identifiers

PMID27194811
PMCPMC4959851
OpenAlexW2400891738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.